Back

Indegene Ltd.

IPO Details · GMP · Subscription · Financials

✅ Listed NSE & BSE Mainboard Live Chart
Issue Price
₹452
Per Share
GMP
NIL
Grey Market
Est. Listing
₹452
Expected Price
Min. Application
₹29,832
2 lots × 33 shares
IPO Issue Details
Issue Price / Price Band₹452 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size33 Shares per Lot
Total Issue Size4,07,66,550 shares (aggregating up to ₹1,841.76 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenMon, 06 May 2024
Subscription CloseWed, 08 May 2024
Anchor AllotmentFri, 03 May 2024
Basis of AllotmentThu, 09 May 2024
Initiation of RefundsFri, 10 May 2024
Credit of Shares to DematFri, 10 May 2024
Listing DateMon, 13 May 2024
UPI Mandate Deadline2024-05-08
Application & Investment Details
Retail — Min (1 Lots)₹14,916 — 33 shares
Retail — Max (13 Lots)₹193,908 (13 Lots)
HNI — Min (14 Lots)₹2,08,824 — 462 shares
EPS (Pre-IPO)₹11.96
EPS (Post-IPO)₹13.48
P/E Ratio (Pre-IPO)37.78x
P/E Ratio (Post-IPO)33.53x
Pre-IPO Promoter Holding22,24,35,091 shares
Post-IPO Promoter Holding23,92,49,250 shares
Fresh Issue Shares1,68,33,818 shares (aggregating up to ₹760.52 Cr)
Offer for Sale Shares2,39,32,732 shares of ₹2 (aggregating up to ₹1,081.24 Cr)
About Indegene Ltd.

Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.The company's services can be divided into following categoriesEnterprise Commercial SolutionsOmnichannel ActivationEnterprise Medical SolutionsEnterprise Clinical Solutions and consultancy servicesThe subsidiary of the company, DT Associates Limited, provides consulting services under the "DT Consulting" brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.As of December 31, 2023, the company had 65 clients actively engaged with its services.As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.

Objects of the Issue

Indegene Ltd. proposes to utilise the net proceeds from the Issue for the following objects:

1
Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.;
2
Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.; and
3
General corporate purposes and inorganic growth.
Shareholding & Lock-in
Pre-IPO Promoter Holding 22,24,35,091 shares
Post-IPO Promoter Holding 23,92,49,250 shares
Lock-in Period (30%)June 8, 2024
Lock-in Period (50%)August 7, 2024
Check AllotmentCheck Status →
Indegene Ltd. — Live Price LIVE
₹452.00
INR · BSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Indegene Ltd. is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹452.00 Live Price
Quick Facts
GMP Signal ⚪ No GMP
StatusListed
Issue Price₹452
GMPNIL
Est. Listing₹452
Lot Size33 shares
Min Amount₹29,832
Listing Date13 May 2024
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹452
Listing Date13 May 2024
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
TOTAL 40,766,550 100.00% ₹1,842.65 Cr
* Based on ₹452.00 (upper price band)
Lot Size & Investment Details
Lot Size
33
Shares
Issue Price
₹452.00
Per Share
Min Investment
₹14,916
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 33 ₹14,916
Retail (Max) 13 429 ₹193,908
sNII (Min) 14 462 ₹208,824
bNII (Min) 68 2,244 ₹1,014,288
Company Financials — Restated Consolidated (Amount in Crore)
Particulars31 Dec 202331 Mar 202331 Mar 2022
Revenue from Operations 1969.75 2364.10 1690.50
EBITDA N/A N/A N/A
Profit After Tax (PAT) 241.90 266.10 162.82
Net Worth 1327.00 1063.72 763.90
Total Assets 2518.15 2203.87 1353.47
Reserves & Surplus 1282.65 1019.43 763.55
Total Borrowings 399.33 394.34 18.24
Key Ratios & Valuation
Issue Price ₹452
Face Value ₹2 Per Share
P/BV 7.55
RoE N/A
RoCE N/A
RoNW 18.23%
PAT Margin (%) 12.62%
EBITDA Margin (%) N/A
Debt / Equity 0.30
Company Details
Company
Indegene Ltd.
Exchange
NSE & BSE
IPO Type
Mainboard IPO
Issue Type
Bookbuilding IPO
Face Value
₹2 Per Share
Script Code
N/A
Address
Aspen Block G4, 3 rd Floor, Manyata Embassy, Business Park, Outer Ring Road, Nagawara Bengaluru, Karnataka, 560045
Book Running Lead Managers
Kotak Mahindra Capital Co.Ltd.
Book Running Lead Manager (BRLM)
Citigroup Global Markets India Pvt.Ltd.
Book Running Lead Manager (BRLM)
JP Morgan India Pvt.Ltd.
Book Running Lead Manager (BRLM)
Nomura Financial Advisory & Securities (India) Pvt.Ltd.
Book Running Lead Manager (BRLM)